Obesity Tied to Higher Risk of Breast Cancer Recurrence on Aromatase Inhibitors

Breast cancer patients with obesity may derive less of a benefit from aromatase inhibitors than patients of a “healthy” weight, according to researchers. The team found that obesity was associated [...]